Covid Medicines
Covid Medicines News

Why manufacturing licence of Remdesivir was not given to pharmaceutical PSUs, asks Parliamentary panel
Since Remdesivir has been included in the National Treatment Protocol as an optional drug in curing critical coronavirus patients, the committee recommended that the Centre conduct scientific studies to check the efficacy of the drug and asked it to explore possibilities to manufacture COVID essential drugs by PSUs under it


Parliamentary panel for framing price control regime for COVID medicines, medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19

First batch of DRDO’s anti-COVID drug 2-DG to be released today
The defence ministry said clinical trials showed that the drug helps in a faster recovery of hospitalised patients and reduces supplemental oxygen dependence

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir
Molnupiravir is an oral antiviral agent, currently being studied in a Phase 3 trial for the treatment of non-hospitalised COVID-19 patients

SC asks Centre for ‘national plan’ on oxygen, medicine supply as India registers world’s highest spike in COVID cases
Delhi HC had earlier ordered the Centre to provide oxygen by whatever means to hospitals facing shortage, observing it 'seems human life is not important for the state'


A blood test can tell which COVID-19 patient should get steroid treatment and who would react adversely to it
The study suggested steroid therapy may benefit patients with severe inflammation, but may negatively impact those with less severe inflammation


Mosquitoes cannot spread COVID-19, Kansas State University finds after studying three most common vectors species
Mosquitoes are common vectors of a number of infectious pathogens, but WHO has maintained that COVID-19 is a respiratory disease that spreads through droplets and fomites.

Maharashtra makes Aadhaar card, positive test, doctor's prescription mandatory to buy COVID-19 drugs
The anti-viral drug remdesivir was cleared for 'restricted emergency use' to treat severe COVID-19 patients last month, causing a spike in demand for the medicine